Protagonist Therapeutics PTGX Shares Withheld For Net Settlement Of Tax Withholding Upon Vesting Of Restricted Stock Units
Shares Withheld For Net Settlement Of Tax Withholding Upon Vesting Of Restricted Stock Units at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept ptgx:SharesWithheldForNetSettlementOfTaxWithholdingUponVestingOfRestrictedStockUnits.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's shares withheld for net settlement of tax withholding upon vesting of restricted stock units.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's shares withheld for net settlement of tax withholding upon vesting of restricted stock units?
- Protagonist Therapeutics (PTGX) reported shares withheld for net settlement of tax withholding upon vesting of restricted stock units of $479K in Q1 2025.
- How has Protagonist Therapeutics's shares withheld for net settlement of tax withholding upon vesting of restricted stock units changed year-over-year?
- Protagonist Therapeutics's shares withheld for net settlement of tax withholding upon vesting of restricted stock units decreased by 20.2% year-over-year, from $600K to $479K.
- What does shares withheld for net settlement of tax withholding upon vesting of restricted stock units mean?
- This represents the value of shares withheld by the company to satisfy statutory tax withholding obligations arising from the vesting of employee equity awards. It is a non-cash financing activity that effectively reduces the number of shares issued to employees. Investors track this to understand the impact of equity compensation programs on share dilution and cash tax obligations.